BRPI0817332A2 - Composição e método de ingrediente sensível estabilizado. - Google Patents
Composição e método de ingrediente sensível estabilizado.Info
- Publication number
- BRPI0817332A2 BRPI0817332A2 BRPI0817332A BRPI0817332A2 BR PI0817332 A2 BRPI0817332 A2 BR PI0817332A2 BR PI0817332 A BRPI0817332 A BR PI0817332A BR PI0817332 A2 BRPI0817332 A2 BR PI0817332A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- sensitive ingredient
- stabilized
- stabilized sensitive
- ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/02—Starch; Degradation products thereof, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2303/00—Characterised by the use of starch, amylose or amylopectin or of their derivatives or degradation products
- C08J2303/02—Starch; Degradation products thereof, e.g. dextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99501907P | 2007-09-24 | 2007-09-24 | |
US4235008P | 2008-04-04 | 2008-04-04 | |
PCT/IB2008/053892 WO2009040750A1 (en) | 2007-09-24 | 2008-09-24 | Composition and method of stabilized sensitive ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0817332A2 true BRPI0817332A2 (pt) | 2015-03-24 |
Family
ID=40336439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0817332 BRPI0817332A2 (pt) | 2007-09-24 | 2008-09-24 | Composição e método de ingrediente sensível estabilizado. |
Country Status (9)
Country | Link |
---|---|
US (1) | US9078824B2 (pt) |
EP (1) | EP2200590A1 (pt) |
CN (1) | CN101801349A (pt) |
AU (1) | AU2008303230B2 (pt) |
BR (1) | BRPI0817332A2 (pt) |
CA (1) | CA2700983C (pt) |
MX (1) | MX339598B (pt) |
RU (1) | RU2466741C2 (pt) |
WO (1) | WO2009040750A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8900557B2 (en) | 2010-12-30 | 2014-12-02 | Jr Chem, Llc | Dental cleaning composition |
WO2012112437A1 (en) | 2011-02-14 | 2012-08-23 | The Procter & Gamble Company | Filmcoated solid dosage forms comprising honey in the coating |
PL2956120T3 (pl) | 2013-02-13 | 2020-08-10 | The Procter & Gamble Company | Leki o smaku anyżu |
AU2015284425B2 (en) | 2014-07-01 | 2021-04-01 | Probi USA, Inc. | Bi-layer dual release probiotic tablets |
WO2016057615A1 (en) * | 2014-10-08 | 2016-04-14 | Alva-Amco Pharmacal Companies, Inc. | Composition for nap promotion |
FR3047663A1 (fr) * | 2016-02-12 | 2017-08-18 | Idl Int Drug Licensing | Comprime dispersible |
MX2019003039A (es) | 2016-09-26 | 2019-07-08 | Procter & Gamble | Forma de dosificacion de alivio prolongado. |
IT202200008018A1 (it) * | 2022-04-22 | 2023-10-22 | Calliero S P A | Processo per la polverizzazione e stabilizzazione di oli essenziali comprendenti furanodieni |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3453368A (en) | 1966-01-13 | 1969-07-01 | Hoffmann La Roche | Smaller high potency compressed tablets of ascorbic acid |
US3480185A (en) | 1966-06-20 | 1969-11-25 | Johnson & Johnson | Charged effervescing agent and medicament dispensing metering valve-actuated aerosol container producing a dose of medicament and carbonation in water |
US4820522A (en) | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
US5047246A (en) * | 1988-09-09 | 1991-09-10 | Bristol-Myers Company | Direct compression cyclophosphamide tablet |
DK0587744T3 (da) | 1991-05-28 | 2003-10-20 | Mcneil Ppc Inc | Tygbar sammensætning til frigørelse af et lægemiddel |
US5409709A (en) | 1991-11-29 | 1995-04-25 | Lion Corporation | Antipyretic analgesic preparation containing ibuprofen |
US5674522A (en) | 1993-10-07 | 1997-10-07 | Mcneil-Ppc, Inc. | Beverage concentrate for drug delivery |
US5500227A (en) | 1993-11-23 | 1996-03-19 | Euro-Celtique, S.A. | Immediate release tablet cores of insoluble drugs having sustained-release coating |
US6210714B1 (en) | 1993-11-23 | 2001-04-03 | Euro-Celtique S.A. | Immediate release tablet cores of acetaminophen having sustained-release coating |
JPH08325145A (ja) | 1995-05-26 | 1996-12-10 | Sumitomo Pharmaceut Co Ltd | 安定なイソプロピルアンチピリン含有製剤 |
AU744156B2 (en) | 1996-10-28 | 2002-02-14 | General Mills Inc. | Embedding and encapsulation of controlled release particles |
JP4384278B2 (ja) | 1998-05-26 | 2009-12-16 | 東亜薬品株式会社 | イブプロフェン含有粒剤 |
US6410052B1 (en) | 1999-03-30 | 2002-06-25 | Purdue Research Foundation | Tea catechins in sustained release formulations as cancer specific proliferation inhibitors |
ATE313319T1 (de) | 1999-03-31 | 2006-01-15 | Janssen Pharmaceutica Nv | Vorgelatinierte stärke in einer formulierung mit gesteuerter freigabe |
US6500463B1 (en) | 1999-10-01 | 2002-12-31 | General Mills, Inc. | Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
US20010043959A1 (en) * | 2000-02-23 | 2001-11-22 | Daniel Gelber | Composition and method for treating the effects of diseases and maladies |
US6787164B2 (en) | 2000-02-23 | 2004-09-07 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
JP2001261580A (ja) | 2000-03-14 | 2001-09-26 | Taisho Pharmaceut Co Ltd | 用時溶解型医薬 |
AR036797A1 (es) | 2001-10-15 | 2004-10-06 | Ferring Bv | Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn |
RU2286156C2 (ru) * | 2001-10-15 | 2006-10-27 | Ферринг Бв | Способ приготовления фармацевтической композиции, включающей в себя 5-аминосалициловую кислоту, для применения в лечении неспецифического язвенного колита и болезни крона |
GB0206861D0 (en) * | 2002-03-22 | 2002-05-01 | Glaxo Group Ltd | Medicaments |
WO2003089007A1 (en) | 2002-04-22 | 2003-10-30 | Adcock Ingram Intellectual Property (Proprietary) Limited | Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
AR040680A1 (es) * | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Composicion de tabletas de liberacion sostenida |
JP4373649B2 (ja) | 2002-08-01 | 2009-11-25 | ロート製薬株式会社 | 経口用液剤 |
US20040101494A1 (en) * | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
US20050232987A1 (en) | 2004-03-12 | 2005-10-20 | Viswanathan Srinivasan | Dosage form containing a morphine derivative and another drug |
DE10359790A1 (de) | 2003-12-19 | 2005-07-21 | Bayer Healthcare Ag | Brausezubereitung einer basischen arzneilich wirksamen Substanz |
GB0330009D0 (en) | 2003-12-24 | 2004-01-28 | Ferrosan As | Probiotic tablet formulations |
WO2006022996A2 (en) | 2004-08-04 | 2006-03-02 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
CN101262852A (zh) * | 2004-12-13 | 2008-09-10 | 麦克内尔-Ppc股份有限公司 | 稳定活性药物成分的组合物和方法 |
CA2591747A1 (en) | 2004-12-23 | 2006-06-29 | Mcneil-Ppc, Inc. | Orally disintegrating pharmaceutical compositions with sensory cue agents |
CN1679525A (zh) * | 2005-01-12 | 2005-10-12 | 复旦大学 | 复方对乙酰氨基酚口腔崩解片 |
US7851006B2 (en) * | 2005-05-23 | 2010-12-14 | Cadbury Adams Usa Llc | Taste potentiator compositions and beverages containing same |
EP1757274B1 (de) | 2005-08-08 | 2012-07-25 | Stada Arzneimittel Ag | Brausezubereitung gegen Erkältungssymptome |
CN1732938A (zh) * | 2005-08-31 | 2006-02-15 | 上海医药(集团)有限公司 | 复方对乙酰氨基酚口腔崩解片 |
US20070141147A1 (en) | 2005-12-21 | 2007-06-21 | Auriga Laboratories, Inc. | Sequential release pharmaceutical formulations |
US20070160695A1 (en) | 2006-01-09 | 2007-07-12 | Clouatre Dallas L | Pharmaceutical preparations for treating hypertension and dyslipidemia with Allium ursinum and Allium sativum |
WO2008011595A2 (en) * | 2006-07-21 | 2008-01-24 | Lab International Srl | Hydrophobic abuse deterrent delivery system |
US8323695B2 (en) * | 2007-08-13 | 2012-12-04 | Mcneil-Ppc, Inc. | Method for stabilizing phenylephrine |
-
2008
- 2008-09-23 US US12/235,711 patent/US9078824B2/en active Active
- 2008-09-24 MX MX2010003250A patent/MX339598B/es active IP Right Grant
- 2008-09-24 WO PCT/IB2008/053892 patent/WO2009040750A1/en active Application Filing
- 2008-09-24 BR BRPI0817332 patent/BRPI0817332A2/pt not_active Application Discontinuation
- 2008-09-24 CA CA 2700983 patent/CA2700983C/en active Active
- 2008-09-24 AU AU2008303230A patent/AU2008303230B2/en active Active
- 2008-09-24 CN CN200880107274A patent/CN101801349A/zh active Pending
- 2008-09-24 EP EP08807791A patent/EP2200590A1/en not_active Withdrawn
- 2008-09-24 RU RU2010106225/15A patent/RU2466741C2/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX339598B (es) | 2016-06-01 |
US20090082316A1 (en) | 2009-03-26 |
EP2200590A1 (en) | 2010-06-30 |
MX2010003250A (es) | 2010-04-09 |
CA2700983C (en) | 2013-07-30 |
CA2700983A1 (en) | 2009-04-02 |
CN101801349A (zh) | 2010-08-11 |
US9078824B2 (en) | 2015-07-14 |
AU2008303230A1 (en) | 2009-04-02 |
AU2008303230B2 (en) | 2014-07-03 |
RU2010106225A (ru) | 2011-11-10 |
RU2466741C2 (ru) | 2012-11-20 |
WO2009040750A1 (en) | 2009-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0917358A2 (pt) | formulação farmacêutica de liberação controlada e método. | |
BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
DK3136030T3 (da) | Fremgangsmåde til lyofilisering | |
BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0809573A2 (pt) | composição, e, método | |
BRPI0922440A2 (pt) | dispositivo protético e método de fabricação do mesmo . | |
BRPI0815588A2 (pt) | Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano | |
BRPI0920284A2 (pt) | composição e método | |
DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
DOP2010000044A (es) | Derivado de oxopirazina y herbicida | |
BRPI0813627A2 (pt) | Peptídio antimicrobiano, composições e métodos de uso | |
BRPI0819232A2 (pt) | composto heterocíclico e composição farmacêutica do mesmo | |
BRPI0817332A2 (pt) | Composição e método de ingrediente sensível estabilizado. | |
DK2254873T3 (da) | Benzodiazepinforbindelse og farmaceutisk sammensætning. | |
BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0814167A2 (pt) | Composição, e, método | |
BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
BRPI0815770A2 (pt) | Composto de organoenxofre contendo flúor e composição pesticida do mesmo | |
BRPI0817844A2 (pt) | Derivados de 3-alcóxi-1-fenilpirazol e pesticidas | |
BRPI0823238A2 (pt) | Composição, e, método | |
BRPI0814748A2 (pt) | Compostos de alditóis substituídos, composições e métodos | |
CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona | |
BRPI0719228A2 (pt) | Composição estabilizada de prostaglandina e |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |